BSE filing, NSE: GENNEX. Summary written from the filing by ALFA Finder's alert engine.
Gennex Laboratories Ltd: key numbers
- Share price
- ₹9.10
- Market cap
- ₹221.1 Cr
- Revenue (annual)
- ₹172.7 Cr
- Net profit (annual)
- ₹20.98 Cr
- P/E (TTM)
- 9.3×Sector 46.1×
- Promoter holding
- 23.63%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gennex Laboratories Ltd
All →Gennex Laboratories Other Announcement
Gennex Laboratories Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Gennex Laboratories Management Change
Gennex Laboratories announced the appointment of Mr. Dipankar Dasgupta as Independent Director, replacing Mr. Amudala Sreeramulu Nageswar Rao, effective October 1, 2026.
Gennex Laboratories Annual General Meeting
Gennex Laboratories Limited held its 41st electronic Annual General Meeting on September 30, 2026. Proceedings included the adoption of financial statements and appointment of company directors.
Gennex Laboratories Annual General Meeting
Gennex Laboratories Limited announced the closure of its register of members from September 23 to September 30, 2026. This is for the upcoming 41st Annual General Meeting.
Gennex Laboratories Board Meeting Outcome
Gennex Laboratories announced the outcome of its board meeting, approving the draft directors' report and scheduling the 41st Annual General Meeting for September 30, 2026.
Gennex Laboratories Board Meeting Date
Gennex Laboratories has announced a board meeting scheduled for September 4, 2026, to discuss the upcoming 41st Annual General Meeting and other business matters.
Other business update announcements
All →OnEMI Technology Solutions Business Update
OnEMI Technology Solutions (Kissht) disclosed its Key Performance Indicators for the quarter ended 30 September 2026. The KPIs, including those defined in its May 2026 prospectus, are published on the company website.
Hero MotoCorp Business Update
Hero MotoCorp updated its code of practices for fair disclosure of unpublished price-sensitive information, effective 28 October 2026. The revised code governs disclosure, spokespersons and analyst interactions.
Cybele Industries Business Update
Cybele Industries disclosed joint venture discussions with a third party, still at an initial stage. No agreement has been executed and no value is stated.
Dr. Reddy's Laboratories Business Update
Dr Reddy's says USFDA closed its PAI and GMP inspection at Srikakulam FTO-SEZ Process Unit-02 with VAI classification. The outcome is closed with no monetary penalty.
Vascon Engineers Business Update
Vascon Engineers awarded Neobridge Realty LLP a Rs.72 Crore shell and core work contract over 25 months. The contract is excluding GST and is described as ordinary course of business.
- Value
- ₹72.00 Cr
- Execution
- 25 months
Meesho Business Update
Meesho's Q2 FY27 shareholders' letter reports NMV up 23% YoY to ₹12,911 crore. Festive timing moved the Mega Blockbuster Sale into Q3.